Literature DB >> 30073840

HIV-1-Mediated Suppression of IFN-α Production Is Associated with Inhibition of IRF-7 Translocation and PI3K/akt Pathway in Plasmacytoid Dendritic Cells.

Ashwini S Dhamanage1, Madhuri R Thakar1, Ramesh S Paranjape1.   

Abstract

Interferon-α (IFN-α) plays a vital role in combating viral infections especially in the early control after infection. However, the HIV infection has shown substantial level of suppression of IFN-α secretion during initial phase of infection. The reasons behind this impairment are still obscure. As plasmacytoid dendritic cells (pDCs) are the major producers of this cytokine, the mechanisms of HIV-1-mediated suppression of IFN-α production by pDCs using the primary pDCs were explored. The nuclear translocation of the interferon regulatory factor (IRF)-7, a transcription factor for IFN-α genes, is essential for the initiation of IFN-α production in pDCs. The HIV-1-exposed pDCs did not show the translocation of IRF-7 into the nucleus in our experiments. Furthermore, it was also observed that HIV-1 inhibited AKT phosphorylation of PI3K/akt pathway in pDCs, an important step for IRF-7 translocation to nucleus. HIV-1-induced inhibition of AKT phosphorylation and IRF-7 translocation was evident even in the presence of Toll-like receptor-7 agonist stimulation and correlated with IFN-α suppression. The findings suggest that HIV-1 may alter AKT phosphorylation to inhibit the translocation of IRF-7 into pDC nucleus, leading to IFN-α suppression, and this may be the reason for IFN-α abrogation observed in recently infected HIV patients. Understanding of interactions between HIV-1 and signaling pathways leading to IFN-α secretion may provide targets for immune intervention.

Entities:  

Keywords:  AKT; HIV-1; IRF-7; interferon-α; plasmacytoid dendritic cells

Mesh:

Substances:

Year:  2018        PMID: 30073840     DOI: 10.1089/AID.2018.0136

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966.

Authors:  Tae Jin Lee; Mitra Nair; Yeshavanth Banasavadi-Siddegowda; Joseph Liu; Tejaswini Nallanagulagari; Alena Cristina Jaime-Ramirez; Jeffrey Yunhua Guo; Haroon Quadri; Jianying Zhang; Kurt H Bockhorst; Manish K Aghi; W Shawn Carbonell; Balveen Kaur; Ji Young Yoo
Journal:  Mol Cancer Ther       Date:  2019-03-29       Impact factor: 6.261

2.  Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.

Authors:  Julie L Mitchell; Hiroshi Takata; Roshell Muir; Donn J Colby; Eugène Kroon; Trevor A Crowell; Carlo Sacdalan; Suteeraporn Pinyakorn; Suwanna Puttamaswin; Khunthalee Benjapornpong; Rapee Trichavaroj; Randall L Tressler; Lawrence Fox; Victoria R Polonis; Diane L Bolton; Frank Maldarelli; Sharon R Lewin; Elias K Haddad; Praphan Phanuphak; Merlin L Robb; Nelson L Michael; Mark de Souza; Nittaya Phanuphak; Jintanat Ananworanich; Lydie Trautmann
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.

Authors:  Shaokun Liu; Zhenlin Wang
Journal:  Dis Markers       Date:  2022-05-26       Impact factor: 3.464

Review 4.  Is there a role for HSF1 in viral infections?

Authors:  Antonia Reyes; Areli J Navarro; Benjamín Diethelm-Varela; Alexis M Kalergis; Pablo A González
Journal:  FEBS Open Bio       Date:  2022-05-10       Impact factor: 2.792

Review 5.  Immunological effector mechanisms in HIV-1 elite controllers.

Authors:  Ciputra Adijaya Hartana; Xu G Yu
Journal:  Curr Opin HIV AIDS       Date:  2021-09-01       Impact factor: 4.061

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.